Methylphenidate on Blue Cross MedicareRx Value (S5715-005)
Covered, with prior authorization required.
Tier 3 (preferred brand). Quantity limit of 90 per 30 days.
$5.98
Patient pays / month, after deductible
$33.23
Patient pays / month, before the $615.00 deductible
$17.94
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
METHYLPHENIDATE HYDROCHLORIDE 5 mg Tablet at a preferred retail pharmacy, from the plan's negotiated price of $33.23 for a month. Other covered strengths are listed below.
Prior authRequired on all 7 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 7 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| METHYLPHENIDATE HYDROCHLORIDE 10 mg Tablet | 3 | $8.13 | PA · 90 per 30 days |
| METHYLPHENIDATE HYDROCHLORIDE 10 mg Tablet, Extended Release | 4 | $45.82 | PA · 90 per 30 days |
| METHYLPHENIDATE HYDROCHLORIDE 10 mg/5mL Solution | 4 | $100.11 | PA · 900 per 30 days |
| METHYLPHENIDATE HYDROCHLORIDE 20 mg Tablet | 3 | $10.79 | PA · 90 per 30 days |
| METHYLPHENIDATE HYDROCHLORIDE 20 mg Tablet, Extended Release | 4 | $45.61 | PA · 90 per 30 days |
| METHYLPHENIDATE HYDROCHLORIDE 5 mg Tablet | 3 | $5.98 | PA · 90 per 30 days |
| METHYLPHENIDATE HYDROCHLORIDE 5 mg/5mL Solution | 4 | $51.51 | PA · 450 per 30 days |
Verify with the plan before prescribing or filling. Member services: (888)285-2249. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s5715-005